Literature DB >> 2596729

Hospital stay and mortality attributed to nosocomial enterococcal bacteremia: a controlled study.

S L Landry1, D L Kaiser, R P Wenzel.   

Abstract

A retrospective cohort study of 97 patients identified by prospective hospital-wide surveillance was conducted to determine the length of hospital stay and mortality attributed to hospital-acquired enterococcal bacteremia. The mean duration of hospitalization for cases was 83 days compared with 44 days for matched controls (p = 0.0001). The mortality rate during the study period was 43% among cases and 12% in matched controls (p less than 0.001). Thus the mortality rate attributable to enterococcal bacteremia was 31% and the risk ratio was 4.75. Stepwise discriminant function analysis indicated that the use of vascular catheters and renal dialysis and the presence of immune deficiency were predictors of fatal outcome in cases. Enterococcal bacteremia has become a prominent nosocomial pathogen and is associated with mortality rates well above those expected from the underlying disease.

Entities:  

Mesh:

Year:  1989        PMID: 2596729     DOI: 10.1016/0196-6553(89)90001-1

Source DB:  PubMed          Journal:  Am J Infect Control        ISSN: 0196-6553            Impact factor:   2.918


  19 in total

1.  Residual attributable mortality, a new concept for understanding the value of antibiotics in treating life-threatening acute infections.

Authors:  Richard P Wenzel; Chris Gennings
Journal:  Antimicrob Agents Chemother       Date:  2010-09-20       Impact factor: 5.191

2.  Is a single positive blood culture for Enterococcus species representative of infection or contamination?

Authors:  K Jindai; M S Strerath; T Hess; N Safdar
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-06-11       Impact factor: 3.267

3.  Enterococcal bacteremia in a tertiary care centre in Winnipeg.

Authors:  T A Madani; A Kabani; P Orr; L Nicolle
Journal:  Can J Infect Dis       Date:  1999-01

Review 4.  Virulence of enterococci.

Authors:  B D Jett; M M Huycke; M S Gilmore
Journal:  Clin Microbiol Rev       Date:  1994-10       Impact factor: 26.132

5.  Anomalous role of tumor necrosis factor alpha in experimental enterococcal infection.

Authors:  Christopher J Papasian; Richard Silverstein; Jian Jun Gao; David M Bamberger; David C Morrison
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

6.  Impact of nosocomial infections on clinical outcome and resource consumption in critically ill patients.

Authors:  Heinz Burgmann; J Michael Hiesmayr; Anne Savey; Peter Bauer; Barbara Metnitz; Philipp G H Metnitz
Journal:  Intensive Care Med       Date:  2010-07-08       Impact factor: 17.440

7.  Bacteremia caused by hemolytic, high-level gentamicin-resistant Enterococcus faecalis.

Authors:  M M Huycke; C A Spiegel; M S Gilmore
Journal:  Antimicrob Agents Chemother       Date:  1991-08       Impact factor: 5.191

8.  Novel interactions of glycosaminoglycans and bacterial glycolipids mediate binding of enterococci to human cells.

Authors:  Irina G Sava; Fuming Zhang; Ioana Toma; Christian Theilacker; Boyangzhi Li; Thomas F Baumert; Otto Holst; Robert J Linhardt; Johannes Huebner
Journal:  J Biol Chem       Date:  2009-04-23       Impact factor: 5.157

9.  Can Enterococcal Infections Initiate Sepsis Syndrome?

Authors:  Peter Linden
Journal:  Curr Infect Dis Rep       Date:  2003-10       Impact factor: 3.725

10.  Importance of the collagen adhesin ace in pathogenesis and protection against Enterococcus faecalis experimental endocarditis.

Authors:  Kavindra V Singh; Sreedhar R Nallapareddy; Jouko Sillanpää; Barbara E Murray
Journal:  PLoS Pathog       Date:  2010-01-08       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.